Clinical Trials Browser

Recruiting × Neoplasm Metastasis × bicalutamide × Clear all

NCT05095207 2025-04-02

Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer

Phase 1/2 Recruiting

Breast Neoplasms, Neoplasm Metastasis